{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T14:39:02Z","timestamp":1787236742929,"version":"build-2736575974"},"reference-count":38,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"21","license":[{"start":{"date-parts":[[2024,5,24]],"date-time":"2024-05-24T00:00:00Z","timestamp":1716508800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,5,24]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>\n                      Hyperlipidemia is a common feature of chronic diseases. The aim of this work was designed to assess the role of probiotics (\n                      <jats:italic toggle=\"yes\">Lactobacillus casei<\/jats:italic>\n                      Zhang,\n                      <jats:italic toggle=\"yes\">Bifidobactetium animalis<\/jats:italic>\n                      subsp.\n                      <jats:italic toggle=\"yes\">lactis<\/jats:italic>\n                      V9, and\n                      <jats:italic toggle=\"yes\">Lactobacillus plantarum P<\/jats:italic>\n                      -8) in the treatment of hyperlipidemia.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>Thirty three patients with hyperlipidemia were randomly divided into a probiotic group (n\u2005=\u200518) and a control group (n\u2005=\u200515). The probiotic group was administered probiotics (2\u2009g once daily) and atorvastatin 20\u2009mg (once daily), and the control group was administered a placebo (2\u2009g once daily) and atorvastatin 20\u2009mg (once daily). Serum and fecal samples were gathered for subsequent analyses.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      Time had a significant effect on the total cholesterol (TC), triglycerides (TG), and low-density lipoprotein-cholesterol (LDL-C) levels in the probiotic and control groups (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005&lt;\u2005.05). The gut microbial abundance in the probiotic group was markedly higher than that in the control group following 3-month probiotic treatment (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005&lt;\u2005.05). At the phylum level, probiotics exerted no notable effects on the relative abundance of\n                      <jats:italic toggle=\"yes\">Firmicutes, Bacteroidetes<\/jats:italic>\n                      , and\n                      <jats:italic toggle=\"yes\">Actinobacteria<\/jats:italic>\n                      but elevated that of\n                      <jats:italic toggle=\"yes\">Tenericutes<\/jats:italic>\n                      and reduced\n                      <jats:italic toggle=\"yes\">Proteobacteria<\/jats:italic>\n                      . At the genus level, probiotics increased the relative abundance of\n                      <jats:italic toggle=\"yes\">Bifidobacterium, Lactobacillus,<\/jats:italic>\n                      and\n                      <jats:italic toggle=\"yes\">Akkermansia,<\/jats:italic>\n                      and decreased that of\n                      <jats:italic toggle=\"yes\">Escherichia, Eggerthella,<\/jats:italic>\n                      and\n                      <jats:italic toggle=\"yes\">Sutterella<\/jats:italic>\n                      relative to the control group in months 1, 2, and 3 (\n                      <jats:italic toggle=\"yes\">P\u2005<\/jats:italic>\n                      &lt;\u2005.05).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>Probiotics optimize the gut microbiota structure and decrease the amount of harmful bacteria in patients with hyperlipidemia. Probiotics can influence the composition of gut microorganisms and increase their diversity and abundance in vivo. It is recommended to use probiotics combined with atorvastatin to treat patients with hyperlipidemia.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/md.0000000000037883","type":"journal-article","created":{"date-parts":[[2024,5,24]],"date-time":"2024-05-24T14:03:08Z","timestamp":1716559388000},"page":"e37883","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":12,"title":["Probiotics combined with atorvastatin administration in the treatment of hyperlipidemia: A randomized, double-blind, placebo-controlled clinical trial"],"prefix":"10.1097","volume":"103","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4183-8243","authenticated-orcid":false,"given":"Yingjie","family":"Tian","sequence":"first","affiliation":[{"name":"Department of Cardiology, Heart Center, Inner Mongolia People\u2019s Hospital, Hohhot, People\u2019s Republic of China"},{"name":"Inner Mongolia Cardiovascular Disease Clinical Research Center, Hohhot, People\u2019s Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guang","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Heart Center, Inner Mongolia People\u2019s Hospital, Hohhot, People\u2019s Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingsheng","family":"Zhao","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Heart Center, Inner Mongolia People\u2019s Hospital, Hohhot, People\u2019s Republic of China"},{"name":"Inner Mongolia Cardiovascular Disease Clinical Research Center, Hohhot, People\u2019s Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heping","family":"Zhang","sequence":"additional","affiliation":[{"name":"Key Laboratory of Dairy Biotechnology and Engineering, Ministry of Education, Inner Mongolia Agricultural University, Hohhot, People\u2019s Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maojia","family":"Ren","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Heart Center, Inner Mongolia People\u2019s Hospital, Hohhot, People\u2019s Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaopeng","family":"Song","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Heart Center, Inner Mongolia People\u2019s Hospital, Hohhot, People\u2019s Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Chang","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Heart Center, Inner Mongolia People\u2019s Hospital, Hohhot, People\u2019s Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zelin","family":"Jing","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Hohhot First Hospital, Hohhot, People\u2019s Republic of China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20250504","doi-asserted-by":"crossref","first-page":"2713","DOI":"10.1007\/s00394-018-1821-z","article-title":"Effects of products designed to modulate the gut microbiota on hyperlipidaemia.","volume":"58","author":"Deng","year":"2019","journal-title":"Eur J Nutr"},{"key":"R2-20250504","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.atherosclerosis.2016.02.006","article-title":"The prevalence, awareness, treatment and control of dyslipidemia among adults in China.","volume":"248","author":"Pan","year":"2016","journal-title":"Atherosclerosis"},{"key":"R3-20250504","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s00281-013-0399-z","article-title":"Gut microbiome and metabolic diseases.","volume":"36","author":"Fukuda","year":"2014","journal-title":"Semin Immunopathol"},{"key":"R4-20250504","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1038\/nrmicro.2016.31","article-title":"Microbiome: restoring healthy growth in infants.","volume":"14","author":"Toit","year":"2016","journal-title":"Nat Rev Microbiol"},{"key":"R5-20250504","doi-asserted-by":"crossref","first-page":"E10539","DOI":"10.1073\/pnas.1810819115","article-title":"Intestinal barrier dysfunction orchestrates the onset of inflammatory host-microbiome cross-talk in a human gut inflammation-on-a-chip.","volume":"115","author":"Shin","year":"2018","journal-title":"Proc Natl Acad Sci USA"},{"key":"R6-20250504","doi-asserted-by":"crossref","first-page":"3793","DOI":"10.1111\/1750-3841.14787","article-title":"Effects of lactobacillus casei YBJ02 on lipid metabolism in hyperlipidemic mice.","volume":"84","author":"Qian","year":"2019","journal-title":"J Food Sci"},{"key":"R7-20250504","doi-asserted-by":"crossref","DOI":"10.3390\/microorganisms7100399","article-title":"Characteristics of gut microbiota in patients with hypertension and\/or hyperlipidemia: a cross-sectional study on rural residents in xinxiang county, henan province.","volume":"7","author":"Li","year":"2019","journal-title":"Microorganisms"},{"key":"R8-20250504","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.jnutbio.2010.10.008","article-title":"Dietary modulation of clostridial cluster XIVa gut bacteria (Roseburia spp.) by chitin-glucan fiber improves host metabolic alterations induced by high-fat diet in mice.","volume":"23","author":"Neyrinck","year":"2012","journal-title":"J Nutr Biochem"},{"key":"R9-20250504","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1039\/C8FO02163E","article-title":"Effects of probiotic supplementation on the regulation of blood lipid levels in overweight or obese subjects: a meta-analysis.","volume":"10","author":"Yan","year":"2019","journal-title":"Food Func"},{"key":"R10-20250504","article-title":"Effects of lactobacillus plantarum Q180 on postprandial lipid levels and intestinal environment: a double-blind, randomized, placebo-controlled, parallel trial.","volume":"12","author":"Park","year":"2020","journal-title":"Nutrients"},{"key":"R11-20250504","first-page":"201","article-title":"Pathogenesis and morphology of coronary atheromatous plaque as an inlet for interpretation of diagnostic imaging.","volume":"13","author":"Hegazy","year":"2022","journal-title":"J Cardiovasc Dis Res"},{"key":"R12-20250504","first-page":"1","article-title":"Myocardial infarction: risk factors, pathophysiology, classification, assessment and management.","volume":"4","author":"Hegazy","year":"2022","journal-title":"Cardiol Res Rep"},{"key":"R13-20250504","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1002\/dmrr.1157","article-title":"Metformin and atorvastatin combination further protect the liver in type 2 diabetes with hyperlipidaemia.","volume":"27","author":"Matafome","year":"2011","journal-title":"Diabetes Metab Res Rev"},{"key":"R14-20250504","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/s12937-019-0483-x","article-title":"Correction to: Nutraceutical approach for the management of cardiovascular risk - a combination containing the probiotic Bifidobacterium longum BB536 and red yeast rice extract: results from a randomized, double-blind, placebo-controlled study.","volume":"18","author":"Ruscica","year":"2019","journal-title":"Nutr J"},{"key":"R15-20250504","doi-asserted-by":"crossref","first-page":"687","DOI":"10.4014\/jmb.1409.09085","article-title":"Effect of lactobacillus rhamnosus hsryfm 1301 on the gut microbiota and lipid metabolism in rats fed a high-fat diet.","volume":"25","author":"Chen","year":"2015","journal-title":"J Microbiol Biotechnol"},{"key":"R16-20250504","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1111\/apt.12758","article-title":"Randomised clinical trial: the beneficial effects of VSL#3 in obese children with non-alcoholic steatohepatitis.","volume":"39","author":"Alisi","year":"2014","journal-title":"Aliment Pharmacol Ther"},{"key":"R17-20250504","doi-asserted-by":"crossref","first-page":"2553","DOI":"10.1007\/s00394-020-02437-4","article-title":"Adjunctive treatment with probiotics partially alleviates symptoms and reduces inflammation in patients with irritable bowel syndrome.","volume":"60","author":"Xu","year":"2021","journal-title":"Eur J Nutr"},{"key":"R18-20250504","doi-asserted-by":"crossref","first-page":"839","DOI":"10.3389\/fbioe.2020.00839","article-title":"Develop and evaluate a new and effective approach for predicting dyslipidemia in steel workers.","volume":"8","author":"Wu","year":"2020","journal-title":"Front Bioeng Biotechnol"},{"key":"R19-20250504","doi-asserted-by":"crossref","first-page":"319","DOI":"10.3109\/08037051.2016.1168969","article-title":"Relationship between body mass index changes and blood pressure changes from childhood to adulthood in a general Chinese population: a 26 year cohort follow-up study.","volume":"25","author":"Wang","year":"2016","journal-title":"Blood Press"},{"key":"R20-20250504","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.2337\/diacare.27.5.1182","article-title":"Can we apply the national cholesterol education program adult treatment panel definition of the metabolic syndrome to asians?","volume":"27","author":"Tan","year":"2004","journal-title":"Diabetes Care"},{"key":"R21-20250504","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1016\/j.mehy.2006.10.038","article-title":"Index of central obesity - a novel parameter.","volume":"68","author":"Parikh","year":"2007","journal-title":"Med Hypotheses"},{"key":"R22-20250504","doi-asserted-by":"crossref","first-page":"447","DOI":"10.26719\/emhj.18.057","article-title":"Prevalence, control and risk factors related to hypertension among Moroccan adults: a multicentre study.","volume":"25","author":"Achhab","year":"2019","journal-title":"East Mediterr Health J"},{"key":"R23-20250504","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1007\/s10068-018-0372-7","article-title":"An exploratory study on the effect of daily fruits and vegetable juice on human gut microbiota.","volume":"27","author":"Choi","year":"2018","journal-title":"Food Sci Biotechnol"},{"key":"R24-20250504","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.atherosclerosis.2015.06.030","article-title":"Supplementation with two probiotic strains, Lactobacillus curvatus HY7601 and Lactobacillus plantarum KY1032, reduces fasting triglycerides and enhances apolipoprotein A-V levels in non-diabetic subjects with hypertriglyceridemia.","volume":"241","author":"Ahn","year":"2015","journal-title":"Atherosclerosis"},{"key":"R25-20250504","doi-asserted-by":"crossref","first-page":"2452","DOI":"10.3168\/jds.S0022-0302(03)73839-9","article-title":"Effects of milk products fermented by Bifidobacterium longum on blood lipids in rats and healthy adult male volunteers.","volume":"86","author":"Xiao","year":"2003","journal-title":"J Dairy Sci"},{"key":"R26-20250504","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1159\/000203284","article-title":"Cholesterol-lowering effect of probiotic yogurt in comparison with ordinary yogurt in mildly to moderately hypercholesterolemic subjects.","volume":"54","author":"Ataie-Jafari","year":"2009","journal-title":"Ann Nutr Metabol"},{"key":"R27-20250504","first-page":"38","article-title":"Effect of probiotics on lipid profile, glycemic control, insulin action, oxidative stress, and inflammatory markers in patients with type 2 diabetes: a clinical trial.","volume":"38","author":"Mazloom","year":"2013","journal-title":"Iranian J Med Sci"},{"key":"R28-20250504","doi-asserted-by":"crossref","first-page":"555","DOI":"10.3920\/BM2018.0134","article-title":"Saccharomyces boulardii CNCM I-745 changes lipidemic profile and gut microbiota in a hamster hypercholesterolemic model.","volume":"10","author":"Briand","year":"2019","journal-title":"Benef Microbes"},{"key":"R29-20250504","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.nutres.2019.03.008","article-title":"Lactobacillus plantarum LC27 and Bifidobacterium longum LC67 simultaneously alleviate high-fat diet-induced colitis, endotoxemia, liver steatosis, and obesity in mice.","volume":"67","author":"Kim","year":"2019","journal-title":"Nutr Res"},{"key":"R30-20250504","doi-asserted-by":"crossref","first-page":"416","DOI":"10.26444\/aaem\/75456","article-title":"Gut microbiome as a biomarker of cardiometabolic disorders.","volume":"24","author":"G\u00f3zd-Barszczewska","year":"2017","journal-title":"Ann Agric Environ Med"},{"key":"R31-20250504","doi-asserted-by":"crossref","first-page":"8601796","DOI":"10.1155\/2020\/8601796","article-title":"The potential role of gut microbiota in the prevention and treatment of lipid metabolism disorders.","volume":"2020","author":"He","year":"2020","journal-title":"Intern J Endocrinol"},{"key":"R32-20250504","doi-asserted-by":"crossref","first-page":"e0187964","DOI":"10.1371\/journal.pone.0187964","article-title":"An in vivo assessment of the cholesterol-lowering efficacy of Lactobacillus plantarum ECGC 13110402 in normal to mildly hypercholesterolaemic adults.","volume":"12","author":"Costabile","year":"2017","journal-title":"PLoS One"},{"key":"R33-20250504","doi-asserted-by":"crossref","DOI":"10.3390\/nu9091021","article-title":"Effects of probiotics, prebiotics, and synbiotics on human health.","volume":"9","author":"Markowiak","year":"2017","journal-title":"Nutrients"},{"key":"R34-20250504","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.jcma.2016.05.002","article-title":"Lactobacillus and health.","volume":"79","author":"Lee","year":"2016","journal-title":"J Chin Med Assoc"},{"key":"R35-20250504","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1038\/s41366-018-0220-0","article-title":"Effects of daily consumption of the probiotic Bifidobacterium animalis subsp. lactis CECT 8145 on anthropometric adiposity biomarkers in abdominally obese subjects: a randomized controlled trial.","volume":"43","author":"Pedret","year":"2019","journal-title":"Int J Obes (Lond)"},{"key":"R36-20250504","doi-asserted-by":"crossref","first-page":"2775","DOI":"10.2337\/db11-0227","article-title":"Responses of gut microbiota and glucose and lipid metabolism to prebiotics in genetic obese and diet-induced leptin-resistant mice.","volume":"60","author":"Everard","year":"2011","journal-title":"Diabetes"},{"key":"R37-20250504","doi-asserted-by":"crossref","first-page":"3181","DOI":"10.1007\/s00253-019-09681-7","article-title":"Beneficial effects of Enterococcus faecalis in hypercholesterolemic mice on cholesterol transportation and gut microbiota.","volume":"103","author":"Zhu","year":"2019","journal-title":"Appl Microbiol Biotechnol"},{"key":"R38-20250504","doi-asserted-by":"crossref","first-page":"e32","DOI":"10.7717\/peerj.32","article-title":"Associations between the human intestinal microbiota, Lactobacillus rhamnosus GG and serum lipids indicated by integrated analysis of high-throughput profiling data.","volume":"1","author":"Lahti","year":"2013","journal-title":"PeerJ"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000037883","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,3]],"date-time":"2025-05-03T20:55:25Z","timestamp":1746305725000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000037883"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,24]]},"references-count":38,"journal-issue":{"issue":"21","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000037883","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,24]]}}}